AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Zoladex (goserelin) — Europe product sales by Year
Zoladex (goserelin) — Europe product sales ($M) ($M)
AstraZeneca Zoladex (goserelin) — Europe product sales: $157M in FY2025, up 6.1% from a year earlier.
Where the FY2025 figure comes from
“|| Zoladex | 1,106 | 5 | 6 | 19 | 17 | 842 | 6 | 8 | 157 | 6 | 3 | 88 | (11) | (10)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Zoladex (goserelin) — Europe product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 157 | +6.1% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 148 | +11.3% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 133 | 0.0% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 133 | -9.5% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 147 | +5.0% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 140 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up zoladex (goserelin) — Europe product sales
Cite this data
StockData. (2026). AstraZeneca Zoladex (goserelin) — Europe product sales ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-zoladex-eu
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.